We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Yu Mi Kang MD, PhD

Yu Mi Kang MD, PhD

Yale New Haven Health, Bridgeport Hospital, Yale School of Medicine, Bridgeport, Connecticut

Dr. Yu Mi Kang is a physician scientist with a clinical and research background in South Korea and the United States. With a main research focus on the cardiovascular complications of diabetes and obesity, she led numerous national-level cardiovascular outcome and mortality studies among people with various cardiometabolic profiles to build a reliable risk stratification model in various ethnic groups. Dr. Kang is deeply interested in the cardiovascular effects of the emerging therapies for diabetes and obesity. She will be joining the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women's Hospital; Harvard Medical School, Boston, MA, for a clinical and research fellowship starting July 2022.

Recent Contributions to PracticeUpdate:

  1. Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide

Most Read This Week

Recently Updated